FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344322811> ?p ?o ?g. }

• W2344322811 endingPage "i39" @default.
• W2344322811 startingPage "i33" @default.
• W2344322811 abstract "Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin(®), Genentech; South San Francisco, CA, USA), a humanized anti-vascular endothelial growth factor (VEGF) monoclonal antibody, is the most widely studied anti-angiogenesis agent both across tumor types and specifically in epithelial ovarian cancer. In 2005, single-agent bevacizumab at 15 mg/kg (IV) every 3 weeks was first reported to be active in a case of recurrent high-grade serous ovarian cancer after failing 11th line cytotoxic treatment. Since then, many case series, phase II and phase III trials have confirmed these results leading to regulatory approval in most countries including the US Food and Drug Administration in 2014. Guidelines now give clear recommendations as to when and how bevacizumab should be integrated into the ovarian cancer treatment paradigm. Other anti-VEGF agents such as the VEGF receptor (VEGFR) tyrosine kinase inhibitors have not shown increased activity or reduced toxicity relative to bevacizumab. However, anti-angiogenics other than anti-VEGF/VEGFR agents such as those targeting Angiopoietin-1 and -2 are in development as well as novel combinations with vascular disrupting agents (VDAs), PARP inhibitors and immune checkpoint inhibitors. Clearly, the benefits of anti-angiogenic agents such as bevacizumab must be carefully weighed against the cost and associated toxicities. Although almost all patients with ovarian cancer will receive an anti-angiogenic compound, cures are not increased. Predictive biomarkers are an urgent unmet need." @default.
• W2344322811 created "2016-06-24" @default.
• W2344322811 creator A5009234043 @default.
• W2344322811 creator A5014611244 @default.
• W2344322811 creator A5089516732 @default.
• W2344322811 date "2016-04-01" @default.
• W2344322811 modified "2023-10-14" @default.
• W2344322811 title "Anti-angiogenic agents in ovarian cancer: past, present, and future" @default.
• W2344322811 cites W1505684888 @default.
• W2344322811 cites W1838939739 @default.
• W2344322811 cites W1866961778 @default.
• W2344322811 cites W1973183162 @default.
• W2344322811 cites W1993944960 @default.
• W2344322811 cites W2000763913 @default.
• W2344322811 cites W2040044819 @default.
• W2344322811 cites W2044421413 @default.
• W2344322811 cites W2064695479 @default.
• W2344322811 cites W2068854353 @default.
• W2344322811 cites W2077823808 @default.
• W2344322811 cites W2081796577 @default.
• W2344322811 cites W2091346065 @default.
• W2344322811 cites W2102195694 @default.
• W2344322811 cites W2102306754 @default.
• W2344322811 cites W2105651363 @default.
• W2344322811 cites W2111658171 @default.
• W2344322811 cites W2113122060 @default.
• W2344322811 cites W2115188495 @default.
• W2344322811 cites W2121740300 @default.
• W2344322811 cites W2123629654 @default.
• W2344322811 cites W2125064537 @default.
• W2344322811 cites W2125853921 @default.
• W2344322811 cites W2133537644 @default.
• W2344322811 cites W2134119471 @default.
• W2344322811 cites W2134947875 @default.
• W2344322811 cites W2135947389 @default.
• W2344322811 cites W2151509048 @default.
• W2344322811 cites W2162645859 @default.
• W2344322811 cites W2163012374 @default.
• W2344322811 cites W2171658624 @default.
• W2344322811 cites W2173026051 @default.
• W2344322811 cites W2199499857 @default.
• W2344322811 cites W2200887263 @default.
• W2344322811 cites W2587481375 @default.
• W2344322811 cites W2599713264 @default.
• W2344322811 doi "https://doi.org/10.1093/annonc/mdw093" @default.
• W2344322811 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6283356" @default.
• W2344322811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27141068" @default.
• W2344322811 hasPublicationYear "2016" @default.
• W2344322811 type Work @default.
• W2344322811 sameAs 2344322811 @default.
• W2344322811 citedByCount "112" @default.
• W2344322811 countsByYear W23443228112016 @default.
• W2344322811 countsByYear W23443228112017 @default.
• W2344322811 countsByYear W23443228112018 @default.
• W2344322811 countsByYear W23443228112019 @default.
• W2344322811 countsByYear W23443228112020 @default.
• W2344322811 countsByYear W23443228112021 @default.
• W2344322811 countsByYear W23443228112022 @default.
• W2344322811 countsByYear W23443228112023 @default.
• W2344322811 crossrefType "journal-article" @default.
• W2344322811 hasAuthorship W2344322811A5009234043 @default.
• W2344322811 hasAuthorship W2344322811A5014611244 @default.
• W2344322811 hasAuthorship W2344322811A5089516732 @default.
• W2344322811 hasBestOaLocation W23443228111 @default.
• W2344322811 hasConcept C121608353 @default.
• W2344322811 hasConcept C126322002 @default.
• W2344322811 hasConcept C143998085 @default.
• W2344322811 hasConcept C167734588 @default.
• W2344322811 hasConcept C2776694085 @default.
• W2344322811 hasConcept C2777025900 @default.
• W2344322811 hasConcept C2777802072 @default.
• W2344322811 hasConcept C2780394083 @default.
• W2344322811 hasConcept C2780427987 @default.
• W2344322811 hasConcept C502942594 @default.
• W2344322811 hasConcept C71924100 @default.
• W2344322811 hasConcept C98274493 @default.
• W2344322811 hasConceptScore W2344322811C121608353 @default.
• W2344322811 hasConceptScore W2344322811C126322002 @default.
• W2344322811 hasConceptScore W2344322811C143998085 @default.
• W2344322811 hasConceptScore W2344322811C167734588 @default.
• W2344322811 hasConceptScore W2344322811C2776694085 @default.
• W2344322811 hasConceptScore W2344322811C2777025900 @default.
• W2344322811 hasConceptScore W2344322811C2777802072 @default.
• W2344322811 hasConceptScore W2344322811C2780394083 @default.
• W2344322811 hasConceptScore W2344322811C2780427987 @default.
• W2344322811 hasConceptScore W2344322811C502942594 @default.
• W2344322811 hasConceptScore W2344322811C71924100 @default.
• W2344322811 hasConceptScore W2344322811C98274493 @default.
• W2344322811 hasLocation W23443228111 @default.
• W2344322811 hasLocation W23443228112 @default.
• W2344322811 hasLocation W23443228113 @default.
• W2344322811 hasLocation W23443228114 @default.
• W2344322811 hasOpenAccess W2344322811 @default.
• W2344322811 hasPrimaryLocation W23443228111 @default.
• W2344322811 hasRelatedWork W1686147318 @default.
• W2344322811 hasRelatedWork W2037617518 @default.
• W2344322811 hasRelatedWork W2042861937 @default.
• W2344322811 hasRelatedWork W2072213084 @default.

• next